Total Payments
$123,772
2024 Payments
$1,639
Companies
46
Transactions
816
Medicare Patients
1,668
Medicare Billing
$192,152
Payment Breakdown by Category
Other$77,626 (62.7%)
Consulting$25,508 (20.6%)
Food & Beverage$18,039 (14.6%)
Travel$2,066 (1.7%)
Education$533.45 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $77,626 | 48 | 62.7% |
| Consulting Fee | $25,508 | 7 | 20.6% |
| Food and Beverage | $18,039 | 743 | 14.6% |
| Travel and Lodging | $2,066 | 11 | 1.7% |
| Education | $533.45 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $64,547 | 193 | $0 (2024) |
| GENZYME CORPORATION | $21,429 | 43 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $12,094 | 42 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $9,485 | 38 | $0 (2019) |
| EMD Serono, Inc. | $6,555 | 40 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,314 | 85 | $0 (2024) |
| ABBVIE INC. | $954.95 | 46 | $0 (2024) |
| Genentech USA, Inc. | $780.28 | 58 | $0 (2024) |
| Eisai Inc. | $737.62 | 28 | $0 (2024) |
| Celgene Corporation | $558.00 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,639 | 57 | ARGENX US, INC. ($307.30) |
| 2023 | $2,312 | 83 | Biogen, Inc. ($930.38) |
| 2022 | $2,173 | 109 | Biogen, Inc. ($379.41) |
| 2021 | $1,879 | 93 | Biogen, Inc. ($369.68) |
| 2020 | $11,185 | 47 | Biogen, Inc. ($10,685) |
| 2019 | $25,413 | 116 | Biogen, Inc. ($16,678) |
| 2018 | $34,267 | 123 | GENZYME CORPORATION ($13,790) |
| 2017 | $44,904 | 188 | Biogen, Inc. ($22,314) |
All Payment Transactions
816 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Neurology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 10/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.87 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Immunology and Neurology | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $129.63 | General |
| Category: Rare Disease | ||||||
| 09/24/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Neurology | ||||||
| 09/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 09/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Rare Disease | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Neuroscience | ||||||
| 07/09/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology and Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 400 | 556 | $269,996 | $49,557 |
| 2022 | 7 | 413 | 546 | $254,564 | $49,326 |
| 2021 | 8 | 496 | 613 | $291,519 | $56,630 |
| 2020 | 4 | 359 | 466 | $213,730 | $36,638 |
Total Patients
1,668
Total Services
2,181
Medicare Billing
$192,152
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 301 | $165,550 | $33,428 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $59,820 | $7,990 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 54 | $20,250 | $4,091 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $17,360 | $2,364 | 13.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $5,130 | $920.38 | 17.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 91 | $1,886 | $764.40 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 228 | $125,400 | $25,445 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $51,844 | $7,973 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 85 | $31,875 | $6,807 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $20,160 | $3,824 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 46 | 54 | $14,040 | $2,776 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $9,685 | $2,270 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 56 | 78 | $1,560 | $231.27 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 156 | $85,800 | $18,878 | 22.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 93 | 93 | $91,251 | $14,365 | 15.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 164 | $61,500 | $12,797 | 20.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 61 | 61 | $34,160 | $6,257 | 18.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $8,940 | $2,107 | 23.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 24 | 30 | $6,750 | $1,369 | 20.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 12 | $1,418 | $602.14 | 42.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 66 | 85 | $1,700 | $255.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 101 | 132 | $72,600 | $12,782 | 17.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 85 | 85 | $72,250 | $12,472 | 17.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 180 | $67,500 | $11,178 | 16.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 55 | 69 | $1,380 | $206.10 | 14.9% |
About Dr. Robyn Wolintz, MD
Dr. Robyn Wolintz, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497760888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robyn Wolintz, MD has received a total of $123,772 in payments from pharmaceutical and medical device companies, with $1,639 received in 2024. These payments were reported across 816 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($77,626).
As a Medicare-enrolled provider, Wolintz has provided services to 1,668 Medicare beneficiaries, totaling 2,181 services with total Medicare billing of $192,152. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 07/31/2006
- Last Updated 03/23/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1497760888
Products in Payments
- TYSABRI (Biological) $30,569
- TECFIDERA (Drug) $26,595
- AUBAGIO (Drug) $21,407
- COPAXONE (Drug) $11,565
- ACTHAR (Biological) $9,620
- Rebif (Biological) $6,364
- ZEPOSIA (Drug) $930.39
- VUMERITY (Drug) $832.09
- Fycompa (Drug) $647.06
- BOTOX (Biological) $607.67
- KESIMPTA (Drug) $559.47
- BRIUMVI (Drug) $548.30
- GILENYA (Drug) $524.29
- UBRELVY (Drug) $503.52
- OCREVUS (Biological) $425.45
- AMPYRA (Drug) $318.91
- Aimovig (Biological) $313.00
- VYVGART HYTRULO (Drug) $307.30
- UPLIZNA (Drug) $262.81
- ULTOMIRIS (Biological) $251.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680
Dr. Daryl Victor, M.d, M.D
Neurology — Payments: $60,707
Neurology $60,707